# DNA Repair Inhibitor & Irradiation on Melanoma

> **NCT01469455** · PHASE1 · COMPLETED · sponsor: **DNA Therapeutics** · enrollment: 27 (actual)

## Conditions studied

- Local Metastatic Melanoma

## Interventions

- **DRUG:** DT01

## Key facts

- **NCT ID:** NCT01469455
- **Lead sponsor:** DNA Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469455, "DNA Repair Inhibitor & Irradiation on Melanoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01469455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*